Amyloid p-peptide (A[3) accumulation and toxicity in the brain are central events in the pathogenesis of Alzheimer's disease (AD). The low-density lipoprotein receptor-related protein (LRP) interacts with p- amyloid-precursor protein (APR) and regulates its endocytic trafficking and processing to Ap. LRP is also the major endocytic receptor for apolipoprotein E (apoE), which interacts with Ap and modulates its cellular clearance. Previous studies have detected abundant functional soluble LRP (sLRP) in peripheral and our preliminary work has detected sLRP in human brain and cerebral spinal fluid (CSF). Molecular and cellular studies have defined Notch/APP-like sequential processing of LRP by matrix metalloprotease (MMP) and by P- and y-secretases. Our long-term goal is to understand how LRP proteolysis is regulated in the brain and dysregulated during AD, and how these proteolytic events and processing products impact its function in APP trafficking and processing to Ap. Our preliminary studies have shown that a y-secretase cleavage product, APP intracellular domain (AICD), regulates LRP expression and function by directly binding to LRP promoter. Our studies also identified a novel adaptor protein, sorting nexin 17 (SNX17), that modulates endocytic trafficking and processing of both LRP and APP. Our central hypothesis is that LRP proteolytic processing is dysregulated in AD by altered expression and function of its processing enzymes and intracellular adaptor proteins and this in turn impairs LRP function in apoE metabolism and signaling in the brain. We propose four specific aims to test our hypothesis: 1) to identify LRP shedding enzymes and examine the functional impacts of altered LRP shedding on apoE metabolism and signaling;2) to study how APP and other y-secretase substrates regulate LRP expression, processing and function;3) to analyze how altered endocytic trafficking of LRP and APP by neuronal adaptor proteins influences their proteolytic processing, apoE metabolism and Ap production;and 4) to examine how LRP proteolysis and the expression of its processing enzymes and adaptor proteins are altered in unique AD transgenic mouse models and during aging and AD in human. Through collaborations with the other projects, our goal in this program project is to define the mechanism of apoE receptor processing and effects on their functions. Our proposed studies may identify novel targets for AD diagnosis and therapy.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG030128-05
Application #
8500094
Study Section
Special Emphasis Panel (ZAG1-ZIJ-4)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
5
Fiscal Year
2013
Total Cost
$202,887
Indirect Cost
Name
University of Illinois at Chicago
Department
Type
DUNS #
098987217
City
Chicago
State
IL
Country
United States
Zip Code
60612
Luo, Jia; Lee, Sue H; VandeVrede, Lawren et al. (2016) A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer's disease. Mol Neurodegener 11:35
DiBattista, Amanda M; Dumanis, Sonya B; Newman, Joshua et al. (2016) Identification and modification of amyloid-independent phenotypes of APOE4 mice. Exp Neurol 280:97-105
Cacciottolo, Mafalda; Christensen, Amy; Moser, Alexandra et al. (2016) The APOE4 allele shows opposite sex bias in microbleeds and Alzheimer's disease of humans and mice. Neurobiol Aging 37:47-57
Fu, Yuan; Zhao, Jing; Atagi, Yuka et al. (2016) Apolipoprotein E lipoprotein particles inhibit amyloid-β uptake through cell surface heparan sulphate proteoglycan. Mol Neurodegener 11:37
Tai, Leon M; Thomas, Riya; Marottoli, Felecia M et al. (2016) The role of APOE in cerebrovascular dysfunction. Acta Neuropathol 131:709-23
Teter, Bruce; LaDu, Mary Jo; Sullivan, Patrick M et al. (2016) Apolipoprotein E isotype-dependent modulation of microRNA-146a in plasma and brain. Neuroreport 27:791-5
Yang, Longyu; Liu, Chia-Chen; Zheng, Honghua et al. (2016) LRP1 modulates the microglial immune response via regulation of JNK and NF-κB signaling pathways. J Neuroinflammation 13:304
Casey, Caroline S; Atagi, Yuka; Yamazaki, Yu et al. (2015) Apolipoprotein E Inhibits Cerebrovascular Pericyte Mobility through a RhoA Protein-mediated Pathway. J Biol Chem 290:14208-17
Zhong, Li; Chen, Xiao-Fen; Zhang, Zhen-Lian et al. (2015) DAP12 Stabilizes the C-terminal Fragment of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) and Protects against LPS-induced Pro-inflammatory Response. J Biol Chem 290:15866-77
Liu, De-shan; Pan, Xiao-dong; Zhang, Jing et al. (2015) APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice. Mol Neurodegener 10:7

Showing the most recent 10 out of 139 publications